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Resumo 
 
Introdução: A vitamina D possui funções endócrinas, parácrinas e autócrinas no organismo. As 
fontes de vitamina D incluem a síntese cutânea através da exposição solar, a alimentação e a 
suplementação. Em Portugal, verifica-se um envelhecimento populacional crescente. Os idosos 
são um grupo de risco para a deficiência de vitamina D, que pode ser considerada uma pandemia 
na Europa, associada a diversas complicações clínicas e a custos económicos. Esta 
problemática tem como principais causas uma ingestão e síntese cutânea inadequadas. A 
síntese cutânea ocorre por ação da radiação ultravioleta B, sendo influenciada por fatores como 
a idade e variáveis que afetam a radiação disponível. O Índice Ultravioleta (IUV) mede o nível de 
radiação que atinge a Terra, passível de causar eritema, variando com fatores como a estação 
do ano e a latitude. O IUV é um possível indicador do potencial de síntese de vitamina D. O 
conhecimento sobre a deficiência de vitamina D, no país, é limitado. É necessário aumentar os 
conhecimentos sobre este problema de saúde pública para garantir a prevenção e tratamento, 
através de uma adequada exposição solar, ingestão alimentar e suplementação. 
 
Objetivo: Explorar a associação entre as concentrações séricas de 25-hidroxivitamina D 
[25(OH)D] de idosos portugueses e o IUV do distrito de residência, tendo em conta outros fatores 
potencialmente influentes nas concentrações de 25(OH)D. 
 
Métodos: Este é um estudo observacional transversal realizado em Portugal, entre dezembro 
de 2015 e junho de 2016, com uma amostra de 1497 idosos (≥65 anos) para os quais se 
recolheram dados sociodemográficos, antropométricos, de estilo de vida, de saúde e de estado 
nutricional. As concentrações séricas de 25(OH)D foram determinadas através de um ensaio de 
eletroquimioluminescência. Todos os dados foram recolhidos no Projeto Nutrition UP 65, exceto 
os do IUV, providenciados pelo Instituto Português do Mar e da Atmosfera. Para cada indivíduo 
calculou-se a média do IUV, do distrito de residência, dos 30 dias prévios à colheita sanguínea. 
Através de análises de regressão linear múltipla explorou-se a associação entre as 
concentrações de 25(OH)D e o IUV, tendo em conta outros fatores potencialmente influentes das 
concentrações de 25(OH)D. 
 
Resultados: A mediana das concentrações de 25(OH)D da amostra foi de 14.40 ng/ml. A 
frequência de deficiência de vitamina D na amostra foi de 69%, segundo o ponto de corte da 
Endocrine Society de 25(OH)D ≤20 ng/ml. Segundo o ponto de corte do Institute of Medicine de 
25(OH)D <12 ng/ml, 39.5% da amostra apresentava risco de deficiência de vitamina D. O IUV 
esteve positivamente associado com as concentrações de 25(OH)D nos modelos de dezembro-
junho (Coeficiente de regressão padronizado [sβ]=0.244, intervalo de confiança a 95% [95% IC]  
0.198; 0.291, P<0.001) e abril-junho (sβ=0.295, 95% IC 0.229; 0.362, P<0.001) e negativamente 
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associado no modelo de dezembro-março (sβ=-0.149, 95% IC -0.211; -0.087, P<0.001). O 
modelo de regressão de dezembro-junho explicou 28% da variância nas concentrações 25(OH)D 
(R2 ajustado=0.280), enquanto os modelos estratificados de dezembro-março e abril-junho 
explicaram cerca de 23% (R2 ajustado=0.229 e 0.232, respetivamente).  
 
Conclusão: A frequência de deficiência de vitamina D nesta amostra de idosos portugueses foi 
elevada. O IUV foi um preditor da concentração de 25(OH)D, mas a sua associação diferiu com 
o período de colheita sanguínea. Os resultados do estudo sugerem que pode ser importante que 
futuras investigações e recomendações sobre a exposição solar e o estado de vitamina D tenham 
em consideração os meses do ano. Outros fatores não avaliados como a alimentação, a 
exposição solar e a genética podem explicar a variância restante nas concentrações de 25(OH)D, 
influenciando o estado de vitamina D desta população.  
 
Palavras-chave: Vitamina D, 25-hidroxitamina D, Deficiência de vitamina D, Idosos, Síntese 
Cutânea, Índice Ultravioleta. 
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Abstract 
 
Introduction: Vitamin D has endocrine, paracrine and autocrine roles in the organism. Sources 
of vitamin D include cutaneous synthesis through sun exposure, diet and supplements. In 
Portugal, population ageing is accelerating. Older adults are a risk group for vitamin D deficiency, 
which could be considered as being pandemic in Europe, and is associated with several clinical 
complications and an economic burden. An inadequate cutaneous synthesis and intake are the 
principal causes for this problem. Cutaneous synthesis occurs by action of ultraviolet B radiation 
and is influenced by factors such as age and variables that affect radiation availability. The 
Ultraviolet Index (UVI) measures the ultraviolet radiation level reaching the Earth likely to cause 
erythema; which varies with factors such as seasons and latitude. The UVI can be an indicator of 
potential for vitamin D synthesis. Knowledge about vitamin D deficiency, in Portugal, is limited. 
There is a necessity to improve knowledge about this public health problem to assure prevention 
and treatment through adequate sun exposure and vitamin D intake from diet and supplements. 
 
Objective: To explore the association between serum 25-hidroxyvitamin D [25(OH)D] 
concentrations of Portuguese older adults and Ultraviolet Index in the district of residence, 
accounting for other potential influential factors of 25(OH)D concentrations.  
 
Methods: This is a cross-sectional observational study conducted in Portugal between December 
2015 and June 2016, in a sample of 1497 older adults (≥65 years) for whom sociodemographic, 
anthropometric, lifestyle, health and nutritional status data were collected. Serum 25(OH)D 
concentrations were determined by a competitive electrochemiluminescence protein binding 
assay. All data were collected in the Nutrition UP 65 Study, except for the UVI, provided by the 
Portuguese Institute for Sea and Atmosphere. For each participant, the mean UVI in the residence 
district, within the 30 days prior to blood collection, was calculated. Multiple linear regression 
analyses were performed to assess the association between 25(OH)D concentrations and 
Ultraviolet Index, accounting for other potential influential factors of 25(OH)D concentrations. 
 
Results: The median 25(OH)D concentration in our sample was 14.40 ng/ml. The frequency of 
deficiency was 69%, according to the Endocrine Society cut-off point of 25(OH)D ≤20 ng/ml. 
According to the Institute of Medicine cut-off point of 25(OH)D <12 ng/ml, 39.5% of the sample 
was at risk for deficiency. The UVI was positively associated with 25(OH)D in the models for 
December-June (Standardized regression coefficient [sβ]=0.244, 95% confidence interval [CI] 
0.198; 0.291, P<0.001) and April-June (sβ= 0.295, 95% CI 0.299; 0.362, P<0.001) and negatively 
associated in the model for December-March (sβ=-0.149, 95% CI -0.211; -0.087,P<0.001). The 
regression model for December-June explained around 28% of variance in 25(OH)D (adjusted 
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R2=0.280), whereas stratified models for December-March and April-June explained around 23% 
(adjusted R2 =0.229 and 0.232, respectively). 
 
Conclusion: In this sample of Portuguese older adults, the frequency of vitamin D deficiency was 
high. The UVI was a predictor of 25(OH)D concentrations but the association varied according to 
the blood collection period. Results of this study suggest that accounting for the time of the year 
in future research and recommendations about sun exposure and vitamin D status may be 
relevant. Other factors nor measured in this work, such as diet, sun exposure and genetics may 
explain the remaining variance in 25(OH)D, influencing vitamin D status of this population of older 
adults. 
 
Keywords: Vitamin D, 25-hydroxyvitamin D, Vitamin D deficiency, Older adults, Cutaneous 
Synthesis, Ultraviolet Index.  
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BMI - Body mass index 
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DBP- Vitamin D Binding Protein 
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Requirements for vitamin D are listed in International Units (IUs). The biological activity of 40 IU 
is equal to 1 µg. 
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I - Introduction 
 
1. Vitamin D 
1.1. Characterization, functions and metabolism 
Vitamin D is a fat-soluble pro-hormone with endocrine, autocrine and paracrine roles in the human 
body (1, 2). The classical function of this vitamin is to maintain bone health and phosphate and 
calcium homeostasis (3, 4). In the 2000’s, research began to focus on extra-skeletal functions and 
several studies have shown a role in diverse physiological functions. Additionally, vitamin D 
deficiency has been associated with mortality and several illnesses such as cardiovascular and 
autoimmune diseases, some types of cancers and type 1 and 2 diabetes (5,6). 
The term “vitamin D” includes two forms which are secosteroids: vitamin D2 or ergocalciferol and 
vitamin D3 or cholecalciferol. While vitamin D2 is formed by ultraviolet B irradiation (UVB) of 
ergosterol existing in plants, fungi and invertebrates, vitamin D3 is formed by irradiation of 7-
dehydrocolesterol (7DHC) found in vertebrates (7).  
Throughout this dissertation, “vitamin D” refers to D2 or D3, unless stated otherwise. 
 
Sources of vitamin D are cutaneous synthesis through sun exposure, diet and supplements (4). 
Under normal conditions, photosynthesis in the skin is able to fulfil 80-100% of human vitamin D 
requirements (8, 9).  
 
Ingested or synthesized vitamin D needs to undergo two hydroxylations to acquire biological 
activity (10).  
When ingested vitamin D enters the circulation, it is bound to vitamin D binding protein (DBP) and 
lipoproteins or to DBP in case of synthesized vitamin D3 (10). Afterwards, vitamin D can go to the 
liver or be taken up by peripheral tissues, particularly adipose tissue and muscle (11, 12). Adipose 
tissue is the main site of storage of vitamin D, extending its total half-life in the body to two months 
(12).  
The first hydroxylation of vitamin D occurs in the liver, by vitamin D-25-hydroxylase, to 25-
hydroxyvitamin D [25(OH)D]. which is the predominant form in circulation (10) where it has a half-
life of two to three weeks (13). However, a serum half-life of one to two months has been reported 
(14, 15). Serum 25(OH)D concentrations are typically measured to determine vitamin D status (10). 
The rate and the extent of the increase in serum 25(OH)D concentrations following UV irradiation 
or vitamin D3 ingestion are a function of regulated activity of vitamin D-25-hydroxylase and are 
variable (12, 16). 
In the kidney and other organs, 25(OH)D is hydroxylated to 1,25-dihydroxyvitamin D 
[1,25(OH)2D], which is the hormonal and biologically active form of vitamin D (10). This activation 
is regulated by various factors including parathyroid hormone, calcium and phosphate levels (16).  
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Catabolism of 25(OH)D and 1,25(OH)2D results in inactive products which are excreted mostly 
through the bile (10). 
The molecule 1,25(OH)2D is involved in genomic and extra genomic actions through interaction 
with the vitamin D receptor, which is present in more than 37 cell types, including intestine and 
bone cells (17).  
 
1.2. Diet and supplements - recommendations and current intake  
Very few foods naturally contain vitamin D2 and D3 (18). The major sources are fatty fish such as 
salmon and mackerel, and cod liver oil (19, 20). It is also present in small quantities in meat, egg 
yolk, milk and dairy as well as in some mushrooms (18, 20).  
Fortification of food with vitamin D represents a way of meeting daily recommended intake (21). 
Fortified foods usually include milk and dairy, breakfast cereals, margarine, bread and orange 
juice, depending on the country (19 ,21, 22). 
Vitamin D supplements are commercially available and their use appears to be high in some 
countries (23).  
 
The recommendations for vitamin D intake are different among health entities and countries (18, 
24-26). According to the Institute of Medicine (IOM), assuming minimal sun exposure, the 
Recommended Daily Allowance (RDA) for vitamin D, is 600 International Units (IU)/day(d) for 
ages 1 to 70 years and 800 IU/day for ages ≥71 years (11). The RDA corresponds to serum 
25(OH)D concentrations ≥20 ng/mL because the IOM focused only on bone health and concluded 
that higher concentrations were not consistently associated with greater benefits (11). However, 
some authors consider that these recommendations are too low to reach/maintain optimal 
concentrations when UVB radiation does not allow synthesis (18, 23, 27) and when individuals are at 
risk for vitamin D deficiency (e.g. older people) (8, 18, 23, 28). Without sun exposure, these authors 
recommend an intake of 1000-2000 IU/d of vitamin D (28-30).  
In Portugal, the recommended daily dose (DDR) of vitamin D for adults is 200 IU/day (31). In 2016, 
the European Food Safety Agency has set, for the European adult population, an adequate intake 
of 600 IU/d (32). 
 
Current levels of food supply (19) and vitamin D intake from diet and supplements are inadequate 
to meet the recommendations, in several countries (33, 34), including in Europe (35, 36), and are 
insufficient during the seasons of deficit in sunlight (33, 35). 
Data on vitamin D intake by the Portuguese population, particularly in older adults, is limited. In a 
sample of women living in Porto (2005), intake levels were inadequate in 96% of women aged 
60-69 years (37). 
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1.3. Cutaneous synthesis  
Exposure to sunlight constitutes the main source of vitamin D for most humans (4).  
Cutaneous synthesis of vitamin D occurs during sun exposure, by the action of UVB radiation 
(290-315 nm) that causes the photolysis of 7DHC, in the skin, to previtamin D3 (4). Production of 
previtamin D3 reaches a plateau at 10 to 15% of the original 7DHC content (38). Previtamin D3 
undergoes thermal isomerization in the skin to form vitamin D3, which binds to DBP, entering the 
bloodstream (3).  
Endogenous synthesis of vitamin D is regulated by melanin pigmentation and mostly by 
photochemical degradation (3, 30). Increased pigmentation decreases synthesis because melanin 
pigmentation absorbs UV radiation (3). Therefore, to synthesize the same amount of vitamin D, 
people with darker skin need longer sun exposure than fair-skinned people (3). 
Both previtamin D3 and vitamin D3 can absorb photons when exposed to sunlight and, 
respectively, isomerise and photolyse into inert photoproducts (3). The concentration of these 
photoproducts increases with sun exposure time (3). In this way, sunlight can regulate production 
of vitamin D3 in the skin (30) and vitamin D intoxication by excessive sun exposure is not 
possible(10). 
 
The UV radiation allows vitamin D synthesis and increases serum 25(OH)D concentrations but 
the dose-response relationship is still unclear (39). Besides allowing vitamin D synthesis, UV 
radiation has also deleterious effects such as erythema and some types of cancers (40, 41). Thus, 
recommendations about how much and when individuals should be exposed to sunlight to ensure 
an adequate vitamin D status is a controversial topic (42, 43). To discuss recommendations, it is 
helpful to understand the concept of action spectrum of vitamin D, which describes the relative 
effectiveness of energy at different wavelengths of UV radiation to synthesize previtamin D3 in 
the skin (44). Several action spectra of vitamin D have been proposed, but there is still no standard 
and all have limitations (45, 46). Some authors say that it is similar to the erythema action spectrum 
(42, 47), thus, it is possible to make recommendations of exposure in terms of minimum erythemal 
dose (MED), i.e. the amount (Joule per square metre [J/m2]) of erythemally effective radiation that 
causes a just perceptible reddening of the skin (47). Each person, according to their skin type, will 
have a different MED (47).  
A UV exposure of one-quarter of a personal MED on one-quarter of skin area (hands, face and 
arms) yields a dietary equivalent vitamin D dose of about 1000 IU (45). The exposure time to get 
this recommended UV dose depends on the skin type, time of day, season, location, ambient 
conditions and clothing (45).  
According to various researchers, sensible exposure to sunlight of hands, face, and arms, 5 to 15 
minutes per day, during the spring, summer and autumn in latitudes >37º N and throughout the 
year <37ºN, satisfies the requirements (28, 30). Some authors indicate longer times for satisfying 
requirements whereas others say these requirements are insufficient (45). Maximum vitamin D 
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synthesis occurs at sub-erythemogenic UV doses (less than one MED) and further sun exposure 
does not have beneficial effects (14, 40, 48). Despite the recommendations, the effects of UV 
exposure on vitamin D3 production (48) and 25(OH)D concentrations are complex and remain 
under investigation (45). 
 
1.3.1. Factors influencing cutaneous synthesis 
Vitamin D synthesis in the skin is influenced by environmental and individual factors. 
Environmental factors affect UVB available for skin synthesis and include atmospheric ozone and 
dispersion (49), cloudiness, air pollution, solar zenith angle (which is a function of latitude, season 
and time of day), altitude and surface reflection (1). 
Atmospheric ozone and dispersion, cloudiness and air pollution diminish UVB available for 
synthesis (49, 50). UV irradiance is higher for smaller solar zenith angle, i.e., in regions closer to the 
equator, in the summer and at solar noon (maximum solar elevation) (49). Altitude and surface 
reflection also increase UVB available (49). 
Latitude and season have substantial impact on UVB radiation (45). Vitamin D synthesis usually 
increases from spring to summer and decreases after that (4). This results in a seasonal variation 
of 25(OH)D serum concentrations, which reaches its nadir (minimum) in winter/early spring (4, 51). 
Researchers have described a “vitamin D winter” referring to the months during which solar UV 
radiation is not intense enough to allow synthesis (4, 45, 52), which occurs at latitudes above 
approximately 35º-40ºN (3, 53-55). Many European countries experience a four to six-month “vitamin 
D winter” (45, 52). However, Webb et al (2006) estimated that at 45°N, UV exposure may result in 
vitamin D synthesis at any time of the year (56).  
Kimlin et al (2007) concluded that latitude was the major predictor of the sun’s ability to produce 
vitamin D in the winter but not in the summer, and that the seasonal difference is most marked at 
high latitudes such as 44.4ºN (57). For latitudes >35ºN, the authors consider that monitoring UV is 
crucial to understand adequate sun exposure for vitamin D synthesis (57). At the same time, a 
paradox exists in countries at higher latitudes which show lower prevalence of vitamin D 
deficiency than others closer to the equator, probably due to the population diet (58). Thus, latitude 
by itself is not a good indicator for potential vitamin D production and is not very useful for 
estimating the vitamin D status of a population (41). 
Personal variables determine if and how available UV radiation is used for vitamin D synthesis (47). 
They include age, skin type and variables associated with exposure behaviours such as clothing, 
sun protection, skin area exposed and duration of exposure (1, 47).  
As ageing occurs, the concentration of 7DHC decreases (59). Above the age of 65 there is a 
fourfold reduction in the ability to synthesize vitamin D3 when compared to a younger adult (4, 47). 
Older adults also tend to avoid the sun and be more covered up, decreasing the amount of UV 
that reaches the skin (47, 59, 60).  
Clothing and sunscreen also represent barriers to production of vitamin D (47).  
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Given the environmental, social and physiological factors that may impair adequate exposure to 
UVB radiation (55, 61), sun exposure is often not sufficient for adequate vitamin D production (29). 
For this reason, dietary intake and/or use of supplements are also of great importance (29) 
particularly during periods when vitamin D synthesis is not possible (22, 45, 62, 63). 
 
1.4. The Ultraviolet Index   
The Ultraviolet Index (UVI) is a parameter that describes the level of UV radiation that reaches 
the Earth’s surface, susceptible of causing erythema (49). It was developed to promote public 
awareness of the risks of UV radiation exposure and sun protection (49). The UVI consists of an 
open-ended scale that ranges from 0 to 11+ (64) and values can be grouped into the following 
exposure categories: low (1-2), moderate (3-5), high (6-7), very high (8-10) and extreme (11+) 
(41). As the UVI gets higher, the potential to cause erythema increases and the time it takes to 
occur decreases (41). 
The UVI is defined as “the integral over the spectral UV irradiance on a horizontal plane (Watt per 
square metre per nanometre [W.m-2.nm-1]), weighted with the International Commission on 
Illumination (1987) erythemal action spectrum and multiplied by the factor 40” (65). The UVI 
depends on several variables such as time of day, season and latitude, being higher in the 
summer, at solar noon and lower latitudes (47, 49, 50).  
Typically, UVI forecast is estimated using a computer model that relates the strength of solar UV 
radiation to forecasted stratospheric ozone concentration, aerosol factors, cloud amounts and 
elevation of the ground (66). The daily maximum UVI is usually the value forecasted by the media 
and represents the maximum UV level that occurs during a four-hour period around solar noon(50).  
The UVI can be an indicator of potential for vitamin D synthesis (32, 47), meaning that the higher 
the UVI, the less exposure to sunlight will be needed to produce a certain amount of vitamin D(47). 
Generally, little vitamin D is synthesized at UVI values between 0.5-3 (30). Some authors consider 
that synthesis occurs at UV values ≥3 (67, 68) and inferior values do not supply sufficient vitamin 
D(56). Despite this, other researchers argue that synthesis can occur at UVI <3, although usually 
longer sun exposure times are required (69, 70). Regardless, synthesis is possible at sub-
erythemogenic UV doses (41, 48, 71). 
There are some studies about the relationship between solar exposure and vitamin D synthesis 
and/or status, but studies in vivo are complex (45). The association between ambient UV radiation 
or UVI and 25(OH)D has also been investigated (15, 72-75). Methods to estimate/evaluate sun 
exposure include questionnaires (76), devices to measure sunlight intensity (77) and modelled 
vitamin D-effective UVB availability (78). Most studies that measured sun exposure and UV report 
an association with 25(OH)D concentrations (76, 79). 
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1.5 Vitamin D deficiency 
The pleiotropic effects of vitamin D and its potential of reducing risk of disease indicates the 
importance of maintaining an adequate vitamin D status (4, 19). In addition to vitamin D intake and 
cutaneous synthesis, other factors can influence vitamin D status and predispose individuals to 
deficiency, making them a risk group (80). 
With ageing, there are several biological and behavioural alterations (80), frequently coupled with 
disabilities, that contribute to reduction of the rate of skin synthesis, hydroxylation and response 
of target tissues as well as reduced skin exposure and vitamin D intake (81). Hence, older adults 
are a risk group for vitamin D deficiency (35). 
Taking certain medications (e.g. cholestyramine, anticonvulsants, antiretroviral medications) also 
increases the risk of vitamin D deficiency (18). 
There is an inverse association between body mass index (BMI) and 25(OH)D concentrations (82) 
possibly due to lower synthesis and the uptake of vitamin D by the adipose tissue (18, 83). Obesity 
(BMI >30 kg/m2) has been associated with vitamin D deficiency (18), thus, obese individuals can 
be considered at risk for this nutritional deficiency (18).  
Some studies found that smokers have a lower vitamin D status, while physical activity is 
associated with higher 25(OH)D concentrations, although the causes remain to be determined(41).  
 
There is still no consensus regarding the cut-off points for defining vitamin D deficiency or optimal 
concentrations. The IOM defines 25(OH)D concentrations of <12 ng/ml, 12-19 ng/ml, and ≥20 
ng/m as risk of deficiency, risk of inadequacy and sufficiency of vitamin D, respectively (84). The 
Endocrine Society as well as other experts (19), adopt higher 25(OH)D thresholds for deficiency, 
insufficiency and sufficiency: ≤20 ng/ml, 21–29 ng/ml and ≥30 ng/ml, respectively (18). Cases of 
toxicity due to excess intake of vitamin D are rare (85). Different toxicity levels, based on 25(OH)D 
concentrations, can be found in the literature. Holick (2010) states that toxicity levels are not met 
until 25(OH)D levels reach 150-200 ng/ml (4), while the IOM states that levels >50 ng/ml are 
possibly harmful (84). 
The prevalence of deficiency depends on the cut-off points adopted by the researchers. The IOM 
states that higher serum 25(OH)D thresholds, such as 20 ng/ml, are too high and misclassify most 
people as deficient, creating the “pandemic” that other authors report (86). Nevertheless, more 
experts are drawing attention to the dimension and possible consequences of this problem (7, 24). 
Globally, vitamin D deficiency is a public health problem, estimated to affect one billion people 
across all age groups (7). In Europe, the prevalence of deficiency (<20 ng/ml) is 40.4%, which can 
be considered as being pandemic and entails an economic burden (51). 
In Portugal, data on vitamin D deficiency is scarce and not representative of the population (87).  
Even though large variations in serum 25(OH)D concentrations exist between different European 
countries, inadequacy is most obvious during winter (52), occurring not only at higher latitudes but 
also in southern Europe, especially among older adults (19, 59, 88). Prevalence of vitamin D 
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deficiency (25(OH)D <10 ng/ml) is even higher in the institutionalized elderly, reaching 80% in 
some studies (35, 59).  
The major reasons for this prevalence of inadequacy are avoidance of sun exposure and the 
unawareness that vitamin D in dietary sources is scarce (4, 23).  
In Europe, high latitudes, indoor living, low intake and ineffective vitamin D fortification in most 
countries contribute to low levels of 25(OH)D (89). 
 
Population ageing has been an increasing trend in Europe, particularly in Portugal, where 19% of 
the population was ≥65 years in 2011 (90). The present and projected scenarios pose challenges 
for the social, economic and health sectors (91, 92). Consequences of vitamin D deficiency in this 
age group include osteomalacia and increased risk of muscle weakness (18, 56) falls and fractures 
(27, 93). Additionally, hypovitaminosis D in geriatric population has been associated with an 
increased risk of neuropsychiatric, cardiovascular, endocrine and oncologic diseases (80). 
Grant et al (2007) estimated that increasing 25(OH)D levels to 40 ng/ml could reduce the 
economic burden of disease, in Europe, by 187 million euros/year (89). 
 
Vitamin D deficiency is easily treatable (35) by encouragement of safe and moderate UV exposure, 
increase in food fortification and the provision of higher doses of vitamin D supplements when 
necessary (94). During the winter, fortification and supplementation may be strategies to achieve 
adequate levels (23, 61).  
More research is needed to develop and prove effectiveness of new strategies to help ensure 
adequate vitamin D intakes critical to the overall health and prevention of chronic diseases in 
high-risk groups (23, 29, 61).  
Additionally, it is important that nutritionists and other health care professionals educate the public 
and regulatory agencies about the relevance of implementing dietary strategies to 
achieve/preserve adequate vitamin D status in the population (29). Public awareness coupled with 
health policies can improve public health at moderate costs (45). 
All the aspects cited in this chapter highlight the relevance of studying the factors that can 
influence vitamin D status in the older population, namely UVI, in Portugal. This study is relevant 
because it is the first to explore the association of UVI and vitamin D status in this high-risk 
population for vitamin D deficiency, in Portugal, and may provide some suggestions to future 
research and to face this problem. 
2. Nutrition UP 65 study  
“Nutritional Strategies Facing an Older Demographic: The Nutrition UP 65 Study” (NUP65S) was 
a study developed by Faculty of Nutrition and Food Sciences of the University of Porto (87), 
conducted in Portugal in older adults, between December 2015 and June 2016. The main 
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objectives were to reduce the nutrition inequalities and provide knowledge about older 
Portuguese adults’ nutritional status (87). Vitamin D status was one of the investigated areas (87). 
II – Objective 
This study aimed to explore the association between serum 25-hidroxyvitamin D [25(OH)D] 
concentrations of Portuguese older adults and Ultraviolet Index in the district of residence, 
accounting for other potential influential factors of 25(OH)D concentrations. 
 
III – Methods  
 
Sampling and Recruiting  
In order to achieve a representative sample of Portuguese older adults, a quota sampling 
approach, using data from Census 2011 regarding sex, age, educational level and regional area, 
was implemented. 
Eligible individuals were Portuguese with 65 years of age or more. The sample was constituted 
by community-dwelling individuals and individuals institutionalized in retirement homes, 
representing the 5% proportionality prevailing in the population.  
The regional areas used were defined in the Nomenclature of Territorial Units for Statistics: 
Alentejo, Algarve, Azores, Lisbon Metropolitan Area, Centre, Madeira and North (NUTS II).  
A random and stratified cluster sampling was applied. In each regional area, three or more town 
councils with >250 inhabitants were randomly selected. Potential community-dwelling participants 
were contacted via home approach, telephone or via institutions (town councils and parish 
centres) whereas institutionalized participants were contacted via institutions. Potential 
participants were informed about the NUP65S and were invited to participate. In case of 
acceptance, participants signed the Informed consent form. Individuals presenting any condition 
that unbaled the collection of venous blood samples or urine (eg, dementia or urinary 
incontinence) were excluded from the NUP65S.  
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Study locations 
In total, 15 districts were selected: 13 districts of mainland Portugal which were Aveiro, Braga, 
Coimbra, Évora, Faro, Leiria, Lisboa, Portalegre, Porto, Santarém, Setúbal, Viana do Castelo and 
Viseu; in addition to Ponta Delgada (São Miguel Island) from the Azores Archipelago and Funchal 
(Madeira Island) from the Madeira Archipelago. 
 
Ultraviolet Index  
Daily maximum UVI forecast was provided by the Portuguese Institute of Sea and Atmosphere 
(IPMA), for the studied districts and the period between November 2015 and July 2016. The 
provided UVI forecast corresponded to the daily maximum UVI around the solar noon and was 
obtained by the German Meteorological Service (DWD) (66, 95). The DWD's UVI forecast has a 
modular structure and is adjusted for cloud modification factors (95). 
 
Study Design and Setting  
The NUP65S is a cross-sectional observational study conducted in Portugal, in a sample of 1500 
subjects (≥65 years old), representative of the older Portuguese population in terms of age, sex, 
education and regional area. Data were collected between December 2015 and June 2016. The 
complete description of NUP65S can be read elsewhere (87). 
The present study is a cross-sectional and observational study and was conducted with a sub-
sample of 1497 older adults (≥65 years) from the NUP65S. Three individuals were excluded from 
the original NUP65S sample: one subject was excluded because the respective serum 25(OH)D 
concentration was 178.10 ng/ml, which was above the toxicity level (150 ng/ml), and two subjects 
were excluded due to missing data. All data of this study were obtained in the NUP65S except 
for the UVI and latitude data. 
 
Data collected in Nutrition UP 65 Study   
The following information was collected through a structured questionnaire: cognitive 
performance, social and demographic data (sex, age, educational level, professional occupation 
and activity, marital status, residence and monthly household income), lifestyle (current smoking 
habits, consumption of alcoholic beverages, physical activity and adherence to Mediterranean 
Diet), skin phenotype, health status and clinical history, as well as hydration, nutritional and 
vitamin D status. The interviews were conducted by eight registered nutritionists previously 
trained.  
The methodology of NUP65S considered relevant to this dissertation is described in detail. 
 
Skin phenotype  
Skin phenotype was self-reported by the participants according to Fitzpatrick (1975) classification 
(96). This scale comprises six skin phenotypes (I-VI) according to melanin pigmentation and the 
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response to UV exposure (97). Across the scale, skin type becomes darker and less susceptible 
to erythema. The classification was the following: Type I - white, very fair, red or blond hair, blue 
eyes, freckles (always burns, never tans); Type II - white, fair, red or blond hair, blue, hazel, or 
green eyes (usually burns, tans with difficulty); Type III - cream white, fair with any eye or hair 
colour, (sometimes a mild burn, gradually tans); Type IV – brown, typical Mediterranean 
Caucasian skin, (rarely burns, tans with ease); Type V - dark brown, mid-eastern skin types (very 
rarely burns, tans very easily) and Type VI - black (never burns, tans very easily) (98). 
 
Cognitive performance  
Cognitive performance was assessed by the Portuguese version of the Mini Mental State 
Examination (MMSE) (99). This examination consists of 30 questions (each scored one point if 
correct) and assesses the functions of registration, orientation, attention, calculation, recall, 
language and ability to follow simple commands. The cut-off scores for cognitive impairment were 
as follows: individuals with no education, ≤15 points; 1 to 11 years of school completed, ≤22 
points; and >11 years of school completed, ≤27 points (99).  
 
Physical activity  
To estimate the physical activity level, the short form of the International Physical Activity 
Questionnaire (IPAQ) Short Form was applied (100). This questionnaire collects information about 
the time spent on different activities (walking, moderate and vigorous activities) in the last seven 
days. Each activity corresponds to a specified energy expenditure in metabolic equivalent task 
(METs) (100). Data collected with IPAQ was converted to MET-minutes. Median values were 
calculated for the different activities using established formulas (100, 101). Kilocalories were 
computed from MET-minutes/week scores and participants were classified as either presenting a 
low physical activity, if <383 kcal/week (men) and <270 kcal/week (women), or normal physical 
activity if ≥383 kcal/week (men) and ≥270 kcal/week (women) (102).  
 
Adherence to the Mediterranean diet and Fish/Shellfish consumption 
Adherence to the Mediterranean diet (MeDi) was assessed by the Portuguese version of the 
Prevention with Mediterranean Diet tool (PREDIMED) (103). This tool was created to test the 
association between Mediterranean diet and obesity indexes and comprises 14 questions, each 
scored with zero or one point. The criteria for assigning one point was previously established: a 
final score ≥10 designated a high adherence to MeDi and <10 designated a low adherence (104). 
The final score of this tool was analysed because a greater adherence to a MeDi has been related 
to a better nutrient profile and a lower prevalence of inadequate micronutrient intake (105). One of 
the 14 questions could include food with high content of vitamin D, which was: “How many 
servings of fish or shellfish do you consume per week (1 serving: 100-150g of fish or 4-5 units or 
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200g of shellfish)?” (104). Criteria for one point was ≥3 servings per week (104). The answer to this 
question was analysed because it could be related to vitamin D intake and status.  
 
Health Status  
Health status was assessed by subject’s self-perceived health, which was categorized as follows: 
very good, good, moderate, bad and very bad (106). 
 
Supplement intake  
Supplement intake was self- reported by the participants. Supplement intake included vitamin D 
and/or multivitamins containing vitamin D.  
 
Nutritional status  
Detailed anthropometric measurements were performed by the registered nutritionists. Body 
weight was measured with a portable calibrated electronic scale (Seca 803) (with a 0.1-kilogram 
(kg) resolution) and standing height was measured with a stadiometer (with a 0.1-centimetres 
(cm) resolution), following standard procedures (107). When it was not possible to obtain these 
measures, weight was estimated from mid-upper arm and calf circumferences, measured with 
metal tape measure (Lufkin) with 0.1centimetre resolution, and height was estimated from 
nondominant hand length, measured with a rated paquimeter (Fervi Equipment) with 0.1-
centimetre resolution. 
Body mass index (BMI) was calculated using the standard formula [weight(kg)/height2(metres2)]. 
According to BMI categories, participants were classified as underweight (<18.5 kg/m2), normal 
range (18.5-24.9 kg/m2), overweight (25-29.9 kg/m2) and obese (≥30 kg/m2) (108).  
The Mini Nutritional Assessment® – Short Form (MNA®-SF) was also administered to assess the 
nutritional status of the participants. The MNA®-SF is a validated nutrition screening and 
assessment tool that can identify older adults (≥65 years old) who are malnourished or at risk of 
malnutrition (109, 110). This tool consists of six questions regarding food intake, weight loss, physical 
and mental status, and anthropometry through BMI assessment (109, 110). According to the score, 
each participant was classified as: undernourished (≤7 out of 14 points), at risk of undernutrition 
(8-11 points) or normal nutritional status (12-14 points).  
 
Vitamin D Status  
Vitamin D status was assessed by dosing the serum levels of 25-hidroxyvitamin D3 [25(OH)D] 
(ng/ml). Blood samples were collected by qualified nurses after the questionnaire and after a 12-
hour fasting period. Blood collection occurred between December 2015 and June 2016, although 
the time period was not the same for all the districts. Therefore, blood collection occurred only for 
five or less months in some districts.  
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All serum 25(OH)D concentrations were analysed in the same equipment (Cobas Roche) in one 
central laboratory (General Lab), in Portugal, by a competitive electrochemiluminescence protein 
binding assay using Roche Diagnostic Vitamin D Total assay (Roche Diagnostics GmbH, 
Mannheim, Germany) (111). The detection limit of this test is 3.00 ng/ml (111). 
 
Ethics 
The NUP65 research was performed according to the guidelines established by the Declaration 
of Helsinki, and the study protocol was approved by the Ethics Committee of the department of 
Social Sciences and Health (Ciências Sociais e Saúde) from the Faculty of Medicine of University 
of Porto (PCEDCSS – FMUP 15/2015) and by the Portuguese National Commission of Data 
Protection (9427/2015) (87). 
 
Statistical Analysis  
The mean of daily maximum UVI for the 30 days prior to the respective blood collection date 
(mUVI) was calculated for each participant. This time period was chosen for several reasons. In 
the literature, half-life of serum 25(OH)D has been reported to be of 1 month (14), 4 weeks to 2 
months (15) or from 2 to 3 weeks (12). Also, the lag-time between the change in monthly UV dose 
and the corresponding change in 25(OH)D levels has been reported to range from 4 to 8 weeks 
(75) (112). Additionally, associations between serum 25(OH)D and UVI over the previous 30 days(75) 
and over the previous 35 days (15) have been found in the literature.  
The UVI was treated both as a categorical and a continuous variable. 
The variable serum 25(OH)D concentrations (ng/ml) was treated as a continuous variable.  
Mean latitudes of the studied districts were calculated based on the participants’ postal code. 
Data in descriptive statistics are presented as median and first and third quartile (Q1 and Q3) of 
25(OH)D concentrations (due to a non-normal distribution) for each potential influential variable 
of serum 25(OH)D. For presentation of the results, variables were categorized as follows: age 
(65-69, 70-74, 75-79 and ≥80 years old), educational level (0, 1-4, 5-12 and ≥13 years of school 
completed), marital status (Single, divorced or widowed and Married or common-law marriage), 
household income (<500, 500-999, ≥1000 €/month and Does not know or does not declare), skin 
phenotype (I-II, III-IV and V-VI), alcoholic beverages consumption (None, Moderate if 1 drink/d 
for women and 1-2 for men, and Heavy if ≥2 drinks/d for women and ≥3 drinks/d for men) (113), 
nutritional status (Not undernourished and Undernourished/at risk of undernutrition) and period 
of blood collection (December-March which comprises late autumn, winter and early spring, and 
in April-June which comprises spring and early summer). Categorization of period of blood 
collection was based on the fact that there is a seasonal variation in 25(OH)D concentrations (30) 
and several authors found that 25(OH)D concentrations reached its minimum in March or late 
winter/early spring (51) (114-116). Additionally, there have been reports that UV radiation may be too 
low to induce adequate vitamin D synthesis until March, in European countries (78) (117).  
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In descriptive statistics, mUVI was categorized as: Low (1-2), Moderate (3-5), High (6-7) and Very 
high (8-10) (41). 
The assessment of normality of continuous variables was conducted by analysing the skewness 
and the kurtosis values. If both values were within the range of -2 to 2, the distribution was 
considered normal. 
According to 25(OH)D concentrations, participants were compared for several sociodemographic, 
lifestyle, health, nutritional and environmental characteristics. For the dichotomous variables, 
statistical significance of differences in serum 25(OH)D concentrations was assessed with the 
Mann-Whitney test. For variables with >2 categories, differences were tested using Kruskal-Wallis 
test and Mann-Whitney test with Bonferroni correction.  
To illustrate the variation of serum 25(OH)D concentrations and mUVI, during the blood collection 
months, a chart was plotted. The median, Q1 and Q3 of 25(OH)D concentrations, as well as the 
mean and standard deviation (SD) of mUVI were calculated for the participants evaluated in each 
month. Mann-Whitney test with Bonferroni correction was performed to test statistical significance 
of differences in serum 25(OH)D concentrations between consecutive months.  
To explore the association between serum 25(OH)D concentrations and mUVI accounting for 
other potential influential factors, multiple linear regression analyses were conducted using the 
stepwise method. Due to a non-normal distribution of 25(OH)D, the dependent variable, a 
logarithm (log base 10) transformation was conducted [log1025(OH)D]. The following  independent 
variables were included: mUVI (continuous), sex (dichotomous), age (continuous), education 
(categorical), professional activity (dichotomous), marital status (dichotomous), residence 
(dichotomous), household income (categorical), skin phenotype (categorical), cognitive 
performance (continuous), smoking habits (dichotomous), alcoholic beverages consumption 
(categorical), adherence to MeDi (continuous), fish or shellfish consumption ≥3 times/week 
(dichotomous), self-perceived health (categorical), supplement intake (dichotomous), nutritional 
status (continuous) and BMI (continuous). Cognitive performance, measured by MMSE score, 
and nutritional status, measured by MNA®-SF score, were exponentially transformed before 
computing the model in order to achieve a normal distribution. Independent variables were chosen 
based on previous studies. Three multiple linear regression analyses were conducted using the 
same method. A regression analysis was conducted for the entire blood collection period, 
between December and June (Dec-Jun). Additionally, two regression analyses stratified by period 
of blood collection were conducted: between December and March (Dec-Mar) and between April 
and June (Apr-Jun). 
For the results of stepwise linear regression analyses, standardized regression coefficients (sβ) 
and the respective 95% Confidence Interval (95% CI) are presented. The adjusted R-square (R2) 
of the models were used to estimate the proportion of the variance in 25(OH)D explained by the 
model. The regression coefficient was used to estimate the change in 25(OH)D concentrations 
(ng/ml) for each 1 unit increase in mUVI. 
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In the statistical tests, all P-values are two-tailed and statistical significance was assumed for 
P<0.05. Microsoft Excel and the IBM Statistical Package for Social Sciences (SPSS) software 
version 24 were used for data and statistical analysis. 
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IV – Results 
 
Descriptive statistics 
Distribution of the participants by the 15 districts included in the study and the respective mean 
latitudes are shown in Table 1. Mean latitudes of Mainland Portugal districts ranged from 37.1ºN 
to 41.7ºN. The Azores archipelago had a mean latitude of 38.3ºN and Madeira archipelago had 
a mean latitude of 32.7ºN, which was the closest to the equator. 
Table 1. Distribution of the participants by the 15 districts and the respective mean latitude (in 
ascending order of latitude). 
District Latitude (ºN)  n (%) 
Funchal (Madeira) 32.7 30 (2.0) 
Faro  37.1 66 (4.4) 
Ponta Delgada (São Miguel) 38.3 24 (1.6) 
Setúbal 38.6 131 (8.8) 
Évora 38.7 25 (1.7) 
Lisboa 38.9 257(17.2) 
Santarém 39.4 96 (6.4) 
Portalegre 39.5 98 (6.5) 
Leiria 39.8 114 (7.6) 
Coimbra 40.2 145 (9.7) 
Viseu 40.8 14 (0.9) 
Aveiro 40.9 127(8.5) 
Porto 41.2 179 (12.0) 
Braga 41.5 173 (11.6) 
Viana do Castelo 41.7 18 (1.2) 
n- number of subjects  
 
Descriptive data and median 25(OH)D concentrations of the sample, by potential influential 
factors of 25(OH)D, are shown in Table 2.  
Table 2. Median 25(OH)D concentrations of the sample, by potential influential factors of 
25(OH)D. 
Variable n Median (Q1; Q3) P-value 
Sex   <0.001 
Female 872 13.20 (7.75; 21.18)  
Male 625 16.90 (10.45; 24.75)  
Age (years)   <0.001 
65-69 412 17.75 (12.00; 25.60)  
70-74 372 15.30 (10.20; 23.48)  
75-79 319 13.70 (8.10; 23.30)  
≥ 80 394 9.95 (5.80; 17.95)  
(Continued) 
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Table 2. (Continued)    
Variable n Median (Q1; Q3) P-value 
NUTS II   <0.001 
North  468 14.15 (8.13;23.35)  
Centre 391 12.60 (6.90; 20.30)  
Lisbon Metropolitan Area 383 16.90 (11.50; 24.90)  
Alentejo 136 12.25 (8.83; 20.60)  
Algarve 65 14.50 (8.30; 22.10)  
Madeira 30 21.75 (15.68; 29.93)  
Azores 24 17.10 (8.43; 23.98)  
Education (years)   <0.001 
0 212 9.50 (5.40; 14.08)  
1-4  1029 14.80 (8.80; 22.80)  
5-12  188 18.00 (11.68; 26.25)  
≥13  68 18.55 (12.48; 29.98)  
Professionally active   0.038 
No 1462 14.30 (8.70; 22.90  
Yes 30 18.60 (11.73; 26.30)  
Marital Status   <0.001 
Single. divorced or widowed 796 11.90 (6.90; 19.30)  
Married or common-law marriage 700 17.40 (11.43; 25.68)  
Residence   <0.001 
Home 1425 14.70 (8.95; 23.20)  
Institution 72 7.20 (4.12; 15.35)  
Household income (€/month)   <0.001 
<500 248 12.00 (7.03;17.98)  
500-999 305 14.60 (9.65; 23.45)  
≥1000 174 19.45 (13.43; 27.95)  
Doesn’t declare/Doesn’t know 770 14.10 (8.00; 22.75)  
Skin Phenotype   0.064 
I + II 305 14.90 (9.95; 20.75)  
III + IV 1109 14.50 (8.50;23.65)  
V + VI 80 12.00 (7.53; 18.53)  
Cognitive performance (MMSE)   <0.001 
Maintenance 1398 14.60 (8.80; 23.30)  
Impairement 99 11.30 (5.60; 18.50)  
Smoking habits   0.852 
No 1429 14.40 (8.70; 22.98)  
Yes 68 14.45 (9.23; 21.45)  
    
(Continued) 
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Table 2. (Continued)    
Alcoholic Beverages Consumption   <0.001 
Does not drink 952 13.20 (8.10; 20.73)  
Moderate 388 17.60 (9.70; 25.90)  
Heavy 155 16.70 (11.40; 24.70)  
Physical activity (IPAC)   <0.001 
Normal 1234 15.30 (9.40; 23.60)  
Low 261 10.20 (5.95; 19.10)  
Adherence to Mediterranean Diet (PREDIMED)   0.001 
Low 849 13.70 (9.48; 24.20)  
High 648 15.60 (8.20; 21.60)  
Fish/shellfish consumption ≥3 servings/week   0.149 
No 372 14.80 (9.50; 23.93)  
Yes 1125 14.20 (8.40; 22.60)  
Self-perceived health    <0.001 
Very good 69 17.70 (13.00; 25.70)  
Good 409 16.90 (9.80; 25.05)  
Moderate 730 14.10 (8.90; 22.80)  
Bad 232 11.30 (6.20; 17.70)  
Very bad 53 10.20 (6.90; 19.00)  
Supplement intake    <0.001 
No 1369 13.90 (8.40; 22.00)  
Yes 128 21.85 (14.05; 32.95)  
Nutritional Status (MNA®-SF)   <0.001 
Normal nutritional status 1256 15.00 (8.48; 21.45)  
Unndernourished/at risk of undernutrition 241 11.60 (5.90; 18.08)  
Body Mass Index    <0.001 
Underweight 3 15.30 (8.80; a)  
Normal range 248 17.10 (9.30; 26.05)  
Overweight 660 15.45 (9.40; 24.20)  
Obese 582 12.45 (7.60; 20.03)  
mUVI Categories   <0.001 
Low 570 12.00 (6.88;19.40)  
Moderate 518 12.90 (7.98;20.43)  
High 222 18.20 (12.18; 26.23)  
Very High 187 20.80 (15.43; 27.98)  
Period of blood collection   <0.001 
December-March 807 11.20 (6.70; 18.30)  
April-June 690 18.20 (12.20; 26.53)  
n number of subjects (does not always add up to 1497 because of missing data). Q1 First Quartile. Q3 Third 
Quartile. a Q3 was not possible to calculate. P-value for Mann-Whitney (dichotomous variables) or Kruskal-
Wallis test (variables with >2 categories). 
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In this population of older adults, the median (Q1; Q3) of 25(OH)D concentration was 14.40 ng/ml 
(8.80; 22.95 ng/ml). Using cut-off points of the Endocrine Society, 69.0% of the participants had 
deficiency (≤20 ng/m); 19.2% had insufficiency (21-29 ng/ml) and 11.8% had sufficiency (≥30 
ng/ml). If the IOM cut-off points were applied, 39.5% of the participants were at risk of deficiency 
(<12 ng/ml), 29.5% were at risk of inadequacy (12-19 ng/ml) and 31% were sufficient at serum 
25(OH)D levels (≥20 ng/m). Seven individuals had 25(OH)D concentrations between 50-60 ng/ml 
and seven had 25(OH)D concentrations >60 ng/ml. 
Analysing median 25(OH)D concentrations for each variable (Table 2), these were significantly 
lower in women than in men, as well as in participants: with no education (increased from 0 years 
to 5-12 years), institutionalized, not professionally active, not married, with a household income 
of <500 €/month, cognitively impaired, with no alcoholic beverages consumption, with low 
physical activity level, with low adherence to MeDi, with bad and a very bad self-perceived health, 
without supplement intake, undernourished or at risk of undernutrition and whose blood was 
collected in December-March. The 25(OH)D concentrations decreased significantly across the 
age categories, except for the 70-74 and 75-79 years. Obese individuals had lower 25(OH) 
concentrations than individuals with a BMI between 18.5 and 29.9 kg/m2 (Mann-Whitney test 
P<0.001). Concentrations of 25(OH)D increased significantly across mUVI categories (Mann-
Whitney test P<0.001) except for the low and moderate categories. 
 
Variation of mUVI and 25(OH)D by month of blood collection 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Variation of mUVI (mean and SD in error bars) and 25(OH)D (median, Q1 and Q3 in error bars) 
concentrations by month of blood collection. 
The variation of mUVI and 25(OH)D concentrations during the blood collection period is shown in  
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Figure 1, where the mean of mUVI for all districts analysed in each month and the respective 
median 25(OH)D concentrations are presented. The mean of mUVI had its minimum in January 
(1.2) and increased until June, when it reached its peak (7.9). The mUVI was >3 between April 
and June. Although 25(OH)D concentrations increased from December to January and reached 
its nadir in March (median=9.50 ng/ml), differences were not statistically significant between 
consecutive months within this period. After March, 25(OH)D concentrations increased 
significantly between consecutive months until May (all P<0.001), when the median concentration 
(19.20 ng/ml) was not significantly different from June.  
 
Multiple linear regression analysis for the entire blood collection period 
 
Table 3. Factors associated with 25(OH)D by multiple stepwise linear regression analysis for 
1486 older adults participating in a cross-sectional observational study. Model for the period of 
blood collection between December-June. 
Independent variables Sβ (95%CI) P-value 
mUVI 0.244 (0.198; 0.291) <0.001 
Sex a   
Women Reference  
Men -- -- 
Age (years) -0.135 (-0.184; -0.086) <0.001 
Education (years)   
0 -0.060 (-0.106; -0.014) 0,010 
1-4a Reference  
5-12 0.052 (0.007; 0.096) 0.022 
≥13 a --- --- 
Professional activity a   
No Reference  
Yes -- -- 
Marital status   
Single, divorced or widowed Reference  
Married or common-law marriage 0.089 (0.042; 0.137) <0.001 
Residence   
Home Reference  
Institution -0.064 (-0.110; -0.019) 0.006 
Household income (€/month)   
<500 a -- -- 
500-999 0.056 (0.011; 0.101) 0.015 
≥1000 0.099 (0.052; 0.145) <0.001 
Does not know or does not declare  Reference  
(Continued) 
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Table 3. (Continued)   
Independent variables Sβ (95%CI) P-value 
Skin phenotype a   
I + II -- -- 
III + IV Reference  
V+ VI -- -- 
Cognitive performance (MMSE score) a -- -- 
Smoking habits a   
No Reference  
Yes -- -- 
Alcoholic beverages consumption   
None Reference  
Moderate  0.054 (0.011; 0.098) 0.015 
Heavy a -- -- 
Physical activity (IPAQ)   
Normal Reference  
Low -0.078 (-0.124; -0.033) 0.001 
Adherence to MeDI (PREDIMED score) -- -- 
Fish/shellfish consumption ≥3 servings/week -- -- 
No Reference -- 
Yes -- -- 
Self-perceived health   
Very good a -- -- 
Good a -- -- 
Moderate  Reference -- 
Bad -0.051 (-0.096; -0.006) 0.025 
Very bad a -- -- 
Supplement intake   
No Reference  
Yes 0.202 (0.158; 0.245) <0.001 
Nutritional status (MNA®-SF score) 0.070 (0.025; 0.115) 0.002 
BMI (kg/m2) -0.123 (-0.168; -0.079) <0.001 
CI: confidence interval; IPAQ: International Physical Activity Questionnaire; MMSE: Mini Mental State 
Examination; MNA®-SF: Mini Nutritional Assessment® – Short Form. Sβ-Standardized regression 
coefficient 
a Variables or categories that were not included in the final model. 
The model included only 1486 subjects because of missing data. 
 
 
The 25(OH)D concentrations were positively associated with: mUVI (P<0.001), 5-12 years of 
education (P=0.022), being married or in a common-law marriage (P<0.001), household income 
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of 500-999 €/month (P=0.015) and ≥1000 €/month (P<0.001), moderate alcoholic beverages 
consumption (P=0.015), supplement intake (P<0.001) and nutritional status (P=0.002). The 
25(OH)D concentrations were negatively associated with age (P<0.001), BMI (P<0.001), 0 years 
of education (P=0.010), living in an institution (P=0.006), having a low physical activity (P=0.001) 
and a bad self-perceived health (P=0.025). 
The variance in the set of independent variables included in the model explained 28% of the 
variance in 25(OH)D concentrations (adjusted R2 =0.280). 
Of all the continuous variables, UVI had the highest effect on 25(OH)D concentrations (sβ =0.244) 
while supplement intake was the variable with the highest effect of the categorical variables 
(sβ=0.202). 
 
Multiple linear regression analysis stratified by period of blood collection  
 
Table 4. Factors associated with 25(OH)D by multiple stepwise linear regression analysis for the 
period of blood collection between December-March (n=802). 
December – March 
Independent variables Sβ (95%CI) P-value 
mUVI -0.149 (-0.211; -0.087) <0.001 
Age (years) -0.211(-0.276; -0.146) <0.001 
Supplement intake 0.196 (0.134; 0.257) <0.001 
Nutritional status (MNA®-SF score) 0.097 (0.034; 0.159) 0.003 
BMI (kg/m2) -0.164 (-0.226; -0.102) <0.001 
Household income - ≥1000 €/month 0.147 (0.082; 0.211) <0.001 
Household income - 500-999 €/month 0.069 (0.006; 0.132) 0.033 
Residence -0.104 (-0.168; -0.041) 0.001 
Alcoholic beverages consumption - 
Moderate 
0.070 (0.009; 0.132) 0.025 
Self-perceived health - Bad -0.082 (-0.144; -0.020) 0.010 
CI: confidence interval; IPAQ: International Physical Activity Questionnaire; MNA®-SF: Mini Nutritional 
Assessment® – Short Form. Sβ-Standardized regression coefficient 
Only variables that were included in the final model are presented. 
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Table 5. Factors associated with 25(OH)D by multiple stepwise linear regression analysis for the 
period of blood collection between April-June (n=683). 
 
April- June 
Independent variables Sβ (95%CI) P-value 
mUVI 0.295 (0.229; 0.362) <0.001 
Age (years) -0.092 (-0.163; -0.022) 0.010 
Supplement intake 0.246 (0.181; 0.315) <0.001 
Nutritional status (MNA®-SF score) 0.076 (0.007; 0.145) 0.030 
BMI (kg/m2) -0.117 (-0.185; -0.050) 0.001 
Education - 0 years -0.078 (-0.148; -0.010) 0.025 
Marital Status 0.140 (0.072; 0.209) <0.001 
Skin phenotype - V +VI -0.079 (-0.146; -0.013) 0.019 
Cognitive performance (MMSE score) 0.085 (0.016; 0.156) 0.017 
Physical Activity - Low -0.102 (-0.172; -0.034) 0.004 
CI: confidence interval; IPAQ: International Physical Activity Questionnaire; MMSE: Mini Mental State 
Examination; MNA®-SF: Mini Nutritional Assessment® – Short Form. Sβ-Standardized regression 
coefficient.  
Only variables that were included in the final model are presented. 
 
In the model for Dec-Mar, mUVI was negatively associated with 25(OH)D concentrations (Sβ=-
0.149), contrarily to the models for Apr-Jun (Sβ=0.295) and Dec-June. Comparing models for 
Dec-Mar and Apr-Jun, mUVI had a lower effect on 25(OH)D in the first model (Sβ=-0.149 versus 
0.295) and some independent variables included in the models were different. The following 
variables were included in all three models: mUVI, age, supplement intake, nutritional status and 
BMI. Both models explained approximately 23% of the variance in 25(OH)D concentrations (Dec-
Mar: adjusted R2=0.229; Apr-Jun: adjusted: R2=0.232).  
In the models for Dec-Jun and Apr-Jun, while keeping all the other independent variables 
constant, an increase of 1 unit in mUVI was associated with an increase in 25(OH)D of 1.07 ng/ml 
(Regression coefficient=0.030) and 1.12 ng/ml (Regression coefficient=0.049), respectively. 
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V - Discussion  
In this cross-sectional study of Portuguese older adults, the median 25(OH)D concentration was 
14.40 ng/ml. The majority of the subjects (69%) had 25(OH)D concentrations ≤20 ng/ml 
(Endocrine Society cut-off point for deficiency). If more conservative cut-off points, by the IOM, 
were applied, more than one third of the sample (39.5%) would be classified as being at risk of 
deficiency (<12 ng/ml).  
The few studies conducted in Portugal focused on heterogenous population settings and did not 
include just the elderly, which hampers comparisons of results and highlights the relevance of this 
study. Prevalence of moderate (8/10-20 ng/ml) or severe deficiency (<8/10 ng/ml) in Portuguese 
studies ranged from 21 to 67.5% (118-121). In the Survey in Europe on Nutrition and the Elderly: A 
Concerted Action (EURONUT-SENECA study), prevalence of 25(OH)D <12 ng/ml in Portuguese 
men and women was 31% and 33%, respectively (60). The numbers found in the present study 
were higher than those found in most of previous works, but closer to the findings of Santiago et 
al (2012) in a sample of older adults (118). 
In the EURONUT-SENECA study, the mean 25(OH)D levels ranged from 8 to 12 ng/ml in 
Southern European centers (122). In a study with Spanish older adults, 86.3% had vitamin D 
insufficiency (≤30 ng/ml) (123). In the Invecchiare in Chianti (InCHIANTI) study (2007), 
approximately 28.8% of women and 13.6% of men had 25(OH)D <10 ng/ml, and 74.9% of women 
and 51.0% of men had 25(OH)D <20 ng/ml (124). Comparisons should be taken cautiously due to 
discrepancies in latitude of the sample, ethnicity and season of blood collection (51).  
In agreement with previous reports, the observed differences in 25(OH)D levels in our sample, 
were as expected for the following variables: sex (56), age (56), physical activity (73, 125, 126) and BMI 
(114, 115, 127). Institutionalized participants had less than half of the 25(OH)D concentrations of those 
living at home (7.20 versus 14.70 ng/ml), which was also expected (88, 128, 129). Participants that 
reported supplement intake (8.6%) had higher 25(OH)D levels compared to those who did not, 
which is in line with other works (114, 130) (Table 2). 
The serum 25(OH)D concentrations increased across ascending mUVI categories. Other works 
also showed a significant increase in 25(OH)D as UV radiation was more intense (73, 115) (Table 
2). 
As expected, 25(OH)D concentrations were lower in Dec-Mar (late autumn-early spring) than in 
Apr-Jun (spring-early summer) (P<0.001) which reflects the seasonal variation reported for 
25(OH)D levels (114, 117) (Table 2).  
Figure 1, which illustrates the variation of mean mUVi and median 25(OH)D concentrations 
during period of blood collection, showed that 25(OH)D concentrations varied during the blood 
collection period and it is noticeable that these were lower in Dec-Mar than in Apr-Jun. The 
variation of 25(OH)D from December to June was similar to other studies, which have also found 
a minimum in March (or late winter/early spring) (78, 88, 130) and an increase in spring and summer 
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(47, 51, 114-116). In a Portuguese study, 25(OH)D levels were highest in the summer, followed by 
autumn, spring and winter (119). However, similarly to our study, frequency of sufficiency of vitamin 
D (≥ 30 ng/ml) was below 50% in every month (119). In the present study, despite the increase in 
25(OH)D concentrations since April, of the 209 subjects sampled in June, only 17.2% had 
25(OH)D concentrations ≥30 ng/ml and 48.3% had ≥20 ng/ml. 
It is noticeable that although mUVI started to increase in February, the rise of 25(OH)D 
concentrations only started in April, when mUVI was >3. This is in line with statements that UVI 
<3 does not trigger adequate synthesis of vitamin D (67, 68). At latitudes >37ºN, from November 
through February, the amount of UV radiation is usually not enough to initiate cutaneous synthesis 
(117). O’Neill et al (2016) also found that the UV threshold for adequate synthesis was only reached 
in mid-March, in European countries (78). At the same time, there might have been a lag-time 
between a change on monthly UVI and the corresponding change in 25(OH)D levels, which has 
been reported to range from 4 to 8 weeks (4, 72, 75, 112, 131). This lag-time may be linked to synthesis 
of vitamin D and half-life of 25(OH)D (72). One could speculate that the decrease in 25(OH)D 
between January and March might have been influenced by the fact that UVI was not intense 
enough to trigger vitamin D synthesis (67, 68), and/or exposure was not likely to occur due to low 
temperatures, limited hours of sunshine and/or individual factors such as clothing (60, 76, 127). 
Therefore, although UVI was rising, individuals may have been relying on their vitamin D stores 
(116), which could have been insufficient, and 25(OH)D concentrations still declined until March 
(Figure 1). 
The set of independent variables in the model for Dec-Jun (Table 3) explained 28% of the 
variance in 25(OH)D concentrations. This is in line with other studies that explored the relationship 
between 25(OH)D and vitamin D intake, UV exposure, environmental and sociodemographic 
factors, which obtained an adjusted R2 between 21% and 33% (73, 114). The model obtained in a 
study on Dutch older people was able to explain 27% of the variance in 25(OH)D concentrations, 
with sun exposure being the major determinant (114).  
Associations between the independent variables and 25(OH)D were expected, according to 
previous research in middle aged and older populations, for: age (73, 115, 132), household income 
(133, 134), education (115), residence (133, 135), alcoholic beverages consumption (56, 132) self-perceived 
health (73) and BMI (56, 73, 132, 136). 
Most works that included sun exposure measurements or UV radiation availability found these 
were predictors of 25(OH)D concentrations (73, 76, 115, 130, 132). The present study did not measure 
sun exposure, but used UVI as an indicator of potential for synthesis of vitamin D. It was possible 
to find four studies that have explored the association between UVI and 25(OH)D, including by 
multiple regression analysis. Three have shown that UVI was positively associated with 25(OH)D 
and was a predictor of 25(OH)D levels (74, 75) or 25(OH)D <30 ng/ml (137). Greer et al (2013) found 
no correlation between the two variables, presumably due to no sun exposure of their sample (15). 
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The fact that mUVI was a predictor of 25(OH)D levels and that there was a positive association 
between the two is in line with other works. This was also expected since UVB radiation induces 
photolysis of 7DHC and initiates synthesis of vitamin D, if adequate sun exposure occurs (3). 
Supplement intake was an important predictor of 25(OH)D levels, as seen in the literature (132, 125, 
138, 139). Physical activity has also been associated with higher 25(OH)D concentration, similarly to 
this study. Higher sun exposure amongst other factors may be responsible for higher vitamin D 
levels in more active individuals (125, 140). 
Nutritional status, measured by the MNA®-SF score, was positively associated with 25(OH)D. A 
lower score can be related to a decline in food intake and impaired mobility (110). Impaired mobility 
or institutionalization discourages sun exposure in older people and have been associated with 
vitamin D deficiency (128, 141). Thus, participants with lower scores might have been more prone to 
have an inadequate sun exposure and vitamin D intake, which could have contributed to lower 
25(OH)D concentrations.  
Skin phenotype was not included in the model, which occurred in some (142) but not all of the 
studies (115, 133). This could have been influenced by the relative narrow range of skin types in our 
sample. 
The majority of researchers concluded that dietary vitamin D intake (114, 115, 132, 136) and fatty fish 
consumption (138), which were not possible to estimate in the present study, were predictors of 
25(OH)D concentrations. However, fish and shellfish consumption ≥3 servings/week and 
adherence to MeDI were not included in the final model. The lack of discrimination between lean 
and fatty fish, inadequacy of servings and the absence of questions linked to food with a high 
vitamin D content might have contributed to the exclusion of these variables.  
Other unassessed factors, such as sun-related behaviors, diet and genetics, or other factors not 
yet known may account for the remaining variance in 25(OH)D status (72%).  
Stratification by period of blood collection resulted in models with different predictors of 25(OH)D 
and opposite associations between UVI and 25(OH)D (Tables 4 and 5). The coincident predictors 
of 25(OH)D concentrations among the three models were: mUVI, age, supplement intake, 
nutritional status and BMI.  
In the model for Dec-Mar, mUVI was inversely associated with 25(OH)D. This association was 
expected as Figure 1 showed that between Dec-March, 25(OH)D declined despite the fact that 
mUVI was rising. Factors that have been previously discussed for Figure 1 and that were 
observed in other studies could have contributed to this negative association (76, 127, 143).  
Given the Portuguese latitudes, UV may not be high enough to trigger vitamin D synthesis 
between late autumn and early spring in all the districts (3, 53-55). During this period, individuals may 
have to rely on diet and supplements as well as on their vitamin D reserves, which may not last 
all “vitamin D winter” (70). Since vitamin D intake from diet may not be adequate, supplement intake 
may be advisable in older adults (41, 60, 67, 132, 139, 142).  
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In the model for Apr-Jun, mUVI was positively associated with25(OH)D, which is in line with 
previous studies (74, 75, 137). Between spring and early summer, sun exposure is more likely to occur 
(130) and it was expected that the higher UVI (mUVI>3) would promote synthesis and contribute 
(among other factors) to the higher 25(OH)D concentrations, comparatively to Dec-Mar (67, 68).  
The low 25(OH)D concentrations despite UVI >3 is in line with reports of high levels of deficiency 
even in regions with high UVI, particularly in risk groups as the elderly (127, 144). In similar latitudes, 
normal levels are barely reached after summer-autumn (145). Additionally, older people synthesize 
vitamin D less efficiently (67) and tend to avoid the sun, staying at home or in the shade (145), and 
also wear long sleeves and cover the face even when temperatures are high (60, 146, 147). The 
widespread public health advice on skin protection and harmful effects of UV radiation can also 
contribute to limited sun exposure (35, 148).   
The fact that different predictors have been selected in both stratified models and UVI 
associations were opposite may also be related with the characteristics of the different groups of 
participants. 
Nevertheless, UV exposure can increase 25(OH)D in older adults, depending on the season (149, 
150). Moreover, sun exposure during summer is a major determinant for stores of vitamin D (151). 
Therefore, even though deficiency was frequent in this and other works, optimizing vitamin D 
stores is still important to maintain (or to minimize the decline of) vitamin D status during winter, 
for as long as possible (47, 56). 
 
Limitations  
The UVI does not account for human body orientation (68) and is based on the UV spectrum for 
erythema, which some authors argue that diverges from the vitamin D action spectrum (44, 47, 152).  
It was not possible to estimate sun exposure from the collected data and UVI may indicate only 
the potential to synthesize vitamin D. Various factors that were not possible to assess may have 
interfered in this potential, including sun exposure behaviors (such as sunscreen use, clothing, 
duration and location of exposure) and ambient factors such as pollution (45). Genetic factors and 
inter-individual variability might also have affected synthesis and 25(OH)D concentrations (59, 153). 
On the other hand, 25(OH)D concentrations reflect not only sun exposure but also vitamin D 
intake, from diet and supplements (59) and might have been influenced by several factors.  
Although analysis did not account for medication use, some individuals reported the use of 
medication that can influence vitamin D status, which may have interfered with their 25(OH)D 
levels.  
Some participants (9% of the sample) reported to have chronic kidney problems, including renal 
failure. Chronic kidney disease, nephrotic syndrome and other unreported health conditions, 
which can influence vitamin D metabolism, might have affected vitamin D status of our sample. 
One should also note that the dispersion of 25(OH)D concentrations in this sample was high. 
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There are some limitations inherent to the laboratorial methods of dosing 25(OH)D concentrations 
(154). Comparison of 25(OH)D concentrations found in this study with previous works has 
limitations given the considerable variability between different methods and laboratories (154). 
This was a cross-sectional observational study and the measured 25(OH)D concentrations may 
not reflect the long-term 25(OH)D levels (144). Blood collection only encompassed months between 
December and June, which does not represent the variation during the entire year. 
The fact that this is a cross-sectional observational study does not allow the establishment of 
causal relationships, as exposures and findings are seen simultaneously at one particular 
moment in time. Further, the effect of reverse causality may exist in the present work.  
The sample was not randomly selected and a participation bias might have existed. Hence, our 
sample may not be representative of the Portuguese older adults’ population (with exception for 
the characteristics of sex, age, educational level and regional area), which does not allow 
inference of results to the population and constitutes a limitation of this study. 
 
Strengths 
This is the first study to explore the relationship between UVI and 25(OH)D in older people in 
Portugal. The main strengths of this study include the large sample size and the fact that it is 
representative of the population in terms of in terms of age, sex, education, and regional area. 
Also, all the blood samples were analysed at the same laboratory using the same equipment and 
assay, which decreased the variability of 25(OH)D analysis that exists in several works (154).  
The use of UVI instead of latitude and season, as an indicator of potential for vitamin D synthesis, 
constitutes an advantage since UVI accounts for latitude, season and intensity of UV that reaches 
the Earth adjusted for nebulosity and ozone absorption (70). 
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VI - Conclusions 
Vitamin D deficiency was highly frequent in this sample of Portuguese older adults (approximately 
7 in 10 individuals). 
Despite all the factors that can decrease vitamin D synthesis and sun exposure in older adults, 
UVI was a predictor of 25(OH)D concentrations in all the multiple linear regression models.  
The UVI was positively associated with 25(OH)D in December-June and April-June but inversely 
associated in December-March. The studied factors in the overall model explained 28% of the 
variance in 25(OH)D concentrations. 
This study suggests that the association between UVI and vitamin D may be different depending 
on the time of the year and thus, future research and recommendations about sensible sun 
exposure to maintain/achieve vitamin D status should take this into account. Moreover, diet and 
supplements may be more important sources of vitamin D during months when UVI and sun 
exposure are expected to be low/insufficient and should be reinforced accordingly. 
Other predictors of 25(OH)D concentrations included in the models might suggest some 
modifiable factors that could be important to assess in future studies, which can elucidate how 
these can affect vitamin D status in older adults. Nevertheless, other parameters not measured 
in this study, such as sun exposure behaviors and diet may have an impact on vitamin D levels 
in the older population. 
In future works, it may be useful to investigate the long-term variation of 25(OH)D concentrations 
of a population. Additionally, it is important to develop and include in future studies, adequate and 
validated tools that estimate sun exposure, accounting for personal behaviors, as well as vitamin 
D intake from diet and supplements. 
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